John Mclaughlin
Director/Board Member bei SONOMA PHARMACEUTICALS, INC.
Vermögen: 899 $ am 31.03.2024
Profil
John G.
Mclaughlin is the founder of Datastream Medical Imaging Systems, Inc. He is currently the Lead Independent Director at Sonoma Pharmaceuticals, Inc. since 2014.
He previously served as the Chief Executive Officer at CompuMed, Inc. from 2002 to 2007.
From 2011 to 2013, he held the position of Chief Executive Officer at Applied BioCode Corp.
and Applied BioCode, Inc. Prior to that, he was the President of Data Flow Information Systems, Inc. from 2007 to 2011.
In terms of education, Mr. Mclaughlin obtained his undergraduate degree from the State University of New York at Buffalo in 1971.
He also attended The State University of New York for his undergraduate studies.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.07.2023 | 5 414 ( 0,03% ) | 899 $ | 31.03.2024 |
Aktive Positionen von John Mclaughlin
| Unternehmen | Position | Beginn |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Director/Board Member | 20.03.2013 |
Ehemalige bekannte Positionen von John Mclaughlin
| Unternehmen | Position | Ende |
|---|---|---|
| Datastream Medical Imaging Systems, Inc. | Chief Executive Officer | 01.04.2016 |
| APPLIED BIOCODE CORPORATION | President | 01.04.2013 |
Applied BioCode, Inc.
 Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The private company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022. | Chief Executive Officer | 01.04.2013 |
| Data Flow Information Systems, Inc. | President | 01.12.2011 |
| COMPUMED, INC. | Chief Executive Officer | 01.06.2007 |
Ausbildung von John Mclaughlin
| State University of New York at Buffalo | Undergraduate Degree |
| The State University of New York | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| COMPUMED, INC. | Health Services |
| SONOMA PHARMACEUTICALS, INC. | Health Technology |
| APPLIED BIOCODE CORPORATION | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Diagnostic Products Corp.
 Diagnostic Products Corp. Medical SpecialtiesHealth Technology Diagnostic Products Corp. provides immunodiagnostic systems, which includes IMMULITE series of immunoassay systems, more than 75 immunoassays. It also designs and manufactures automated laboratory instrumentation and automation solutions. Diagnostic Products is located in Los Angeles, CA. | Health Technology |
Unipath LLC
 Unipath LLC Medical/Nursing ServicesHealth Services Part of Laboratory Corp. of America Holdings, Unipath LLC is a medical laboratory. The private company is based in Denver, CO. | Health Services |
| Datastream Medical Imaging Systems, Inc. | |
| Data Flow Information Systems, Inc. | |
Applied BioCode, Inc.
Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The private company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022. | Electronic Technology |
